Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dow Jones Industrial Average ETF (DIA) vs Johnson & Johnson (JNJ) Price & Performance

Dow Jones Industrial Average ETFTrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Dow Jones Industrial Average ETF vs Johnson & Johnson — how do they compare? Dow Jones Industrial Average ETF trades at $537.37, while Johnson & Johnson trades at $260.78 (market cap $626.09B). The key difference: Johnson & Johnson pays a 2.06% dividend while Dow Jones Industrial Average ETF pays none. Which is the better fit depends on your goals.

DIAJNJ
52-Week High
$542.79$267.24
52-Week Low
$447.95$174.16
Market Cap
$626.09B
Volume
6,156,228
Sector
Health
Enterprise Value
$654.37B
Dividend Yield
2.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dow Jones Industrial Average ETF

DIA (SPDR Dow Jones Industrial Average ETF) trades at $537.13, down 0.35% on the day, with technical indicators showing a bullish trend supported by moving averages. The ETF's dividend schedule includes upcoming payments of $1.41 and $0.28 per share through mid-2026. Recent market coverage highlights the Dow's milestone above 53,000 points, driven by financials and tech exposure, while broader ETF flows show strong investor interest in core index heavyweights amid defensive positioning.

Outlook remains positive given the Dow's blue-chip composition and recent market momentum, though risks include tech volatility and geopolitical tensions. The ETF offers stable dividend income and exposure to large-cap value stocks, but investors should monitor macroeconomic indicators and Fed policy for potential headwinds.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.

Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Dow Jones Industrial Average ETF

The ETF is designed to track the performance of the securities and the stocks in the Dow Jones Industrial Average Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

Read more on DIA

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ